How Turning Point Therapeutics became a 2019 IPO standout

Turning Point Therapeutics is one of the 2019's IPO's that has been performing better than its cohorts, jumping 23% since its IPO. CEO Dr. Athena Countouriotis joins "Squawk Box" to discuss the business before and after hitting the public market.
Thu, Oct 10 20199:35 AM EDT